Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy

Atsushi Ogura, Tsuyoshi Konishi, Geerard L Beets, Chris Cunningham, Julio Garcia-Aguilar, Henrik Iversen, Shigeo Toda, In Kyu Lee, Hong Xiang Lee, Keisuke Uehara, Peter Lee, Hein Putter, Cornelis J H van de Velde, Harm J T Rutten, Jurriaan B Tuynman, Miranda Kusters, Lateral Node Study Consortium, Atsushi Ogura, Tsuyoshi Konishi, Geerard L Beets, Chris Cunningham, Julio Garcia-Aguilar, Henrik Iversen, Shigeo Toda, In Kyu Lee, Hong Xiang Lee, Keisuke Uehara, Peter Lee, Hein Putter, Cornelis J H van de Velde, Harm J T Rutten, Jurriaan B Tuynman, Miranda Kusters, Lateral Node Study Consortium

Abstract

Importance: Previously, it was shown in patients with low rectal cancer that a short-axis (SA) lateral node size of 7 mm or greater on primary magnetic resonance imaging (MRI) resulted in a high lateral local recurrence (LLR) rate after chemoradiotherapy or radiotherapy ([C]RT) with total mesorectal excision (TME) and that this risk was lowered by a lateral lymph node dissection (LLND). The role of restaging MRI after (C)RT with regard to LLR risk and which specific patients might benefit from an LLND is not fully understood.

Objective: To determine the factors on primary and restaging MRI that are associated with LLR in low rectal cancer after (C)RT and to formulate specific guidelines on which patients might benefit from an LLND.

Design, setting, and participants: In this retrospective, multicenter, pooled cohort study, patients who underwent surgery for cT3 or cT4 low rectal cancer with a curative intent from 12 centers in 7 countries from January 2009 to December 2013 were included. All patients' MRIs were rereviewed according to a standardized protocol, with specific attention to lateral nodal features. The original cohort included 1216 patients. For this study, patients who underwent (C)RT and had a restaging MRI were selected, leaving 741 for analyses across 10 institutions, including 651 who underwent (C)RT with TME and 90 who underwent (C)RT with TME and LLND.

Main outcomes and measures: The main purpose was to identify the factors on primary and restaging MRI associated with LLR after (C)RT with TME. Whether high-risk patients might benefit in terms of LLR reduction from an LLND was also studied.

Results: Of the 741 included patients, 480 (64.8%) were male, and the mean (SD) age was 60.4 (12.0) years. An SA lateral node size of 7 mm or greater on primary MRI resulted in a 5-year LLR rate of 17.9% after (C)RT with TME. At 3 years, there were no LLRs in 28 patients (29.2%) with lateral nodes that were 4 mm or less on restaging MRI. Nodes that were 7 mm or greater on primary MRI and greater than 4 mm on restaging MRI in the internal iliac compartment resulted in a 5-year LLR rate of 52.3%, significantly higher compared with nodes in the obturator compartment of that size (9.5%; hazard ratio, 5.8; 95% CI, 1.6-21.3; P = .003). Compared with (C)RT with TME alone, treatment with (C)RT with TME and LLND in these unresponsive internal nodes resulted in a significantly lower LLR rate of 8.7% (hazard ratio, 6.2; 95% CI, 1.4-28.5; P = .007).

Conclusions and relevance: Restaging MRI is important in clinical decision making in lateral nodal disease. In patients with shrinkage of lateral nodes from an SA node size of 7 mm or greater on primary MRI to an SA node size of 4 mm or less on restaging MRI, which occurs in about 30% of cases, LLND can be avoided. However, persistently enlarged nodes in the internal iliac compartment indicate an extremely high risk of LLR, and an LLND lowered LLR in these cases.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Garcia-Aguilar has received personal fees from Intuitive Surgical, Johnson & Johnson, and Medtronic. Dr H. Lee has received grants from Medtronic. No other disclosures were reported.

Figures

Figure 1.. Time-Dependent Receiver Operating Characteristic Curves…
Figure 1.. Time-Dependent Receiver Operating Characteristic Curves for Short-Axis Node Size on Restaging Magnetic Resonance Imaging at 3 and 5 Years After Surgery in 651 Patients Who Underwent Chemoradiotherapy or Radiotherapy With Total Mesorectal Excision
The dotted line indicates the baseline of receiver operating characteristic curve analysis. The data points indicate the cutoff values of lateral lymph node short-axis sizes. The distance from this line to the data points indicates the capacity of the cutoff value to distinguish positive from negative lateral local recurrence. A, The area under the receiver operating characteristic curve was 0.780. B, The area under the receiver operating characteristic curve was 0.698.
Figure 2.. Kaplan-Meier Analysis of Lateral Lymph…
Figure 2.. Kaplan-Meier Analysis of Lateral Lymph Node Dissection
Kaplan-Meier plot of patients with a short-axis node size of 7 mm or greater on primary magnetic resonance imaging and greater than 4 mm on restaging magnetic resonance imaging located in the internal iliac compartment among patients who received chemoradiotherapy or radiotherapy ([C]RT) with total mesorectal excision (TME) alone and patients who received (C)RT with TME and lateral lymph node dissection (LLND). Crosses indicate censored events.

Source: PubMed

3
S'abonner